Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reginmune is a multi-ingredient dietary supplement and nutraceutical product formulated as a capsule containing a complex blend of phytochemicals, amino acids, vitamins, minerals, and a biological polymer. Its key components include herbal extracts such as **Echinacea** and **Cat's Claw** (*Uncaria tomentosa*), essential minerals like **Zinc**, **Copper**, and **Magnesium**, vitamins (specifically food-derived **Vitamin C**), and amino acids including **L-lysine**, **L-glutamine**, **L-arginine**, and **L-isoleucine**. The formulation also incorporates **Aloe vera** polysaccharides and **Sodium hyaluronate** within a cellular matrix. Reginmune is designed to act as an immunomodulator and antiviral agent, aiming to boost immune cell activity (such as T-cells and Natural Killer cells) and regulate cytokine production (e.g., TNF-alpha and IL-6). It has been clinically evaluated, often in combination with the polyherbal formulation Immunofree, for the treatment of mild to moderate COVID-19 to reduce symptoms and viral load.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Reginmune.